Category: Reyes
-
CannTrust (TRST.C) committee continues Pelham investigation as the sector watches
The investigation via special committee of CannTrust Holdings’ (TRST.C) non-compliance with Health Canada mandated regulations is ongoing, with further information regarding the committee’s membership now available. On July 11, 2019, the committee was appointed by CannTrust’s board of directors to examine how the company’s Pelham, Ontario, facility came to violate Health Canada guidelines. CannTrust’s Pelham…
-
![Aurora Cannabis (ACB.T) comes out on top in Italian tender, but debt looms heavy]()
Aurora Cannabis (ACB.T) comes out on top in Italian tender, but debt looms heavy
Aurora Cannabis (ACB.T) has been named as the sole winner in the Italian medical cannabis tender process, an announcement tempered by worries over the company’s mounting debt and disappointing revenue. On July 18, Aurora fell 1.2% after Bank of America (BAC.NYSE) downgraded the stock’s rating to “neutral” from “buy.” Bank of America analyst, Chris Carey, described Aurora…
-
Balance sheet breakdown: Supreme Cannabis’ (FIRE.T) fundamental supremacy
Supreme (FIRE.T) is an office darling for a few reasons, but none more so than the fact it’s a company you can be proud recommending to friends and family. I know I am. The company’s mission statement is sustaining disciplined growth while delivering high-quality products. Disciplined growth. The wingbeats of cherubs never sounded so sweet. Listen, I…
-
Khiron Life Sciences (KHRN.V) is still the only Colombian company with revenue from legal cannabis
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked. After the acquisition of ILANS and the launch of the cosmeceutical brand, Kuida, Khiron is in a league of its own. There is an endless stream of cannabis companies trying to establish market share in Latin America, including…
-
![ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s]()
ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s
Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable. See, our understanding of Alzheimer’s has changed dramatically since its discovery…
-
![Growing Gurus: ESG, ethical investing and shareholder activism]()
Growing Gurus: ESG, ethical investing and shareholder activism
So you want to be an ethical investor, but soulless multinationals like Exxon Mobil and Walmart have you put off from the capital markets. If this is you, know you’re not alone. But, dear investor, herein lies a problem: large successful companies, the safest stocks to invest in, are the most, for lack of a…
-
Cannabis corner: Chemesis (CSI.C) signs $6M deal, Khiron (KHRN.V) eyes greater EU-LatAm trade and iAnthus (IAN.C) deepens Florida roots
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year lifespan, PR ONE has signed on to purchase a minimum of $300,000 of cannabis infused products and a minimum of $200,000 of flower monthly from Chemesis’…
-
![The trouble with robo advisors]()
The trouble with robo advisors
At a party several months ago, I overheard, and was drawn into, an interesting conversation while en route to the bathroom. The conversation was about finances, naturally. A friend of mine was admonishing another of our mutual friends for a lack of diligence in his financial planning. After years of late-nights and the resulting promotions…
-
Biome Grow (BIO.C) Q1 financials shows benefits of even-handed management and sustainable growth
Biome Grow (BIO.C) has just released its Q1 financials and confirmed what we already knew about management: it’s preference of responsible growth at a defensible rate. The quick ratio is a good metric to apply to developing small-cap companies like Biome Grow. It measures a company’s short-term liquidity and gauges their ability to meet its…
-
Green Organic Dutchman (TGOD.T) must burn for a few days in order to regrow, bigger and better
A reader asked us a few days ago why The Green Organic Dutchman’s (TGOD.T) stock was plummeting over the last few weeks. It’s a fair question. While we were coming up with an answer, TGOD got its sales license. “We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1…
